✦ LIBER ✦

Imatinib mesylate is effective in the treatment of persistent eosinophilia

Book ID: 120863407
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2002
Weight: 133 KB
Volume: 1337
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200213370-00032

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Imatinib Mesylate in the Treatment of Ch

Imatinib Mesylate in the Treatment of Chronic Myelogenous Leukemia

✍ Gautam Borthakur; Jorge E. Cortes 📂 Article 📅 2004 🏛 Carden Jennings Publishing 🌐 English ⚖ 108 KB

Imatinib Mesylate in the Treatment of Di

Imatinib Mesylate in the Treatment of Diffuse Cutaneous Mastocytosis

✍ Marie-Anne Morren; Anne Hoppé; Marleen Renard; Maria Debiec Rychter; Anne Uytteb 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Cost Effectiveness of Imatinib Mesylate

Cost Effectiveness of Imatinib Mesylate in the Treatment of Advanced Gastrointestinal Stromal Tumours

✍ Dr Daniel M. Huse, Margaret von Mehren, Gregory Lenhart, Heikki Joensuu, Charles 📂 Article 📅 2007 🏛 Springer International Publishing AG 🌐 English ⚖ 118 KB

Is there a role for imatinib mesylate in

Is there a role for imatinib mesylate in the treatment of eosinophilic granulomatosis with polyangiitis?

✍ Erre, Gian Luca; Pardini, Simonetta; Cuccuru, Luciana; Taras, Loredana; Passiu, 📂 Article 📅 2015 🏛 Elsevier Science 🌐 English ⚖ 362 KB

Persistence of malignant hematopoietic p

Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment

✍ Bhatia, R. 📂 Article 📅 2003 🏛 American Society of Hematology 🌐 English ⚖ 80 KB

Efficacy of imatinib mesylate in the tre

Efficacy of imatinib mesylate in the treatment of refractory sclerodermatous chronic GVHD

✍ Magro, L; Catteau, B; Coiteux, V; Bruno, B; Jouet, J-P; Yakoub-Agha, I 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 203 KB